Mortgage and refinance interest rates today for August 11, 2025: The 30-year rate stays under 6.5%
According to data from Zillow, rates have increased since this time last year despite earlier optimism that they might go down. Experts also predict that rates will stay above 6% through the next few quarters. According to the Fannie Mae July Housing Forecast, the organization doesn't expect mortgage rates to hit 6% until Q3 2026.
Read next: 2025 housing market — Is now a good time to buy a house?
Current mortgage rates
Here are the current mortgage rates, according to the latest Zillow data:
30-year fixed: 6.44%
20-year fixed: 6.16%
15-year fixed: 5.73%
5/1 ARM: 6.75%
7/1 ARM: 6.58%
30-year VA: 6.07%
15-year VA: 5.57%
5/1 VA: 6.09%
Remember, these are the national averages and rounded to the nearest hundredth.
Learn more: 8 strategies for getting the lowest mortgage rates
Current mortgage refinance rates
These are today's mortgage refinance rates, according to the latest Zillow data:
30-year fixed: 6.48%
20-year fixed: 6.31%
15-year fixed: 5.71%
5/1 ARM: 7.19%
7/1 ARM: 7.08%
30-year VA: 5.91%
15-year VA: 5.57%
5/1 VA: 5.93%
Again, the numbers provided are national averages rounded to the nearest hundredth. Although it's not always the case, mortgage refinance rates tend to be a little higher than purchase rates.
Read more: The best mortgage refinance lenders right now
Refinance interest rates
Up Next
Up Next
Mortgage payment calculator
You can use the free Yahoo Finance mortgage calculator to play around with how different terms and rates will affect your monthly payment. Our calculator considers factors like property taxes and homeowners insurance when estimating your monthly mortgage payment. This gives you a better idea of your total monthly payment than if you just looked at mortgage principal and interest.
But if you want a quick, simple way to see how today's rates would impact your monthly mortgage payment, try out the calculator below:
30-year mortgage rates today
Today's average 30-year mortgage rate is 6.44%. A 30-year term is the most popular type of mortgage because by spreading out your payments over 360 months, your monthly payment is relatively low.
If you had a $300,000 mortgage with a 30-year term and a 6.44% rate, your monthly payment toward the principal and interest would be about $1,884, and you'd pay $378,377 in interest over the life of your loan — on top of that original $300,000.
15-year mortgage rates today
The average 15-year mortgage rate is 5.73% today. Several factors must be considered when deciding between a 15-year and 30-year mortgage.
A 15-year mortgage comes with a lower interest rate than a 30-year term. This is great in the long run because you'll pay off your loan 15 years sooner, and that's 15 fewer years for interest to compound.
However, your monthly payments will be higher because you're squeezing the same debt payoff into half the time.
If you get that same $300,000 mortgage with a 15-year term and a 5.73% rate, your monthly payment would jump to $2,488. But you'd only pay $147,843 in interest over the years.
Dig deeper: How much house can I afford? Use our home affordability calculator.
Adjustable mortgage rates
With an adjustable-rate mortgage, your rate is locked in for a set period of time and then increases or decreases periodically. For example, with a 5/1 ARM, your rate stays the same for the first five years, then changes every year.
Adjustable rates usually start lower than fixed rates, but you run the risk that your rate goes up once the introductory rate-lock period is over. But an ARM could be a good fit if you plan to sell the home before your rate-lock period ends — that way, you pay a lower rate without worrying about it rising later.
Lately, ARM rates have occasionally been similar to or higher than fixed rates. Before dedicating yourself to a fixed or adjustable mortgage rate, be sure to shop around for the best lenders and rates. Some will offer more competitive adjustable rates than others.
How to get a low mortgage rate
Mortgage lenders typically give the lowest mortgage rates to people with higher down payments, excellent credit scores, and low debt-to-income ratios. So if you want a lower rate, try saving more, improving your credit score, or paying down some debt before you start shopping for homes.
You can also buy down your interest rate permanently by paying for discount points at closing. A temporary interest rate buydown (as mentioned early in the article) is also an option — for example, maybe you get a 6.5% rate with a 2-1 buydown. Your rate would start at 4.5% for year one, increase to 5.5% for year two, then settle in at 6.5% for the remainder of your term.
Just consider whether these buydowns are worth the extra money at closing. Ask yourself if you'll stay in the home long enough that the amount you save with a lower rate offsets the cost of buying down your rate before making your decision.
Mortgage rates today: FAQs
What are interest rates today?
Here are interest rates for some of the most popular mortgage terms: According to Zillow data, the national average 30-year fixed rate is 6.44%, the 15-year fixed rate is 5.73%, and the 5/1 ARM rate is 6.75%.
What is a normal mortgage rate right now?
A normal mortgage rate on a 30-year fixed loan is 6.44%. However, keep in mind that's the national average based on Zillow data. The average might be higher or lower depending on where you live in the U.S.
Will mortgage rates drop down?
Mortgage rates are not expected to drop significantly in 2025 — especially over the next couple of weeks while economists keep an eye on inflation, tariffs, and the Federal Reserve. Still, there could be a cut to mortgage rates leading up to the next Fed meeting in September.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
24 minutes ago
- Yahoo
Flowers Foods Inc (FLO) Q2 2025 Earnings Call Highlights: Navigating Market Shifts with ...
Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Flowers Foods Inc (NYSE:FLO) is aggressively transitioning its portfolio to align with current consumer demand, which is expected to drive long-term growth. The company has seen success with its differentiated products, such as Dave's Killer Bread and Canyon Bakehouse, which are performing well in the market. Flowers Foods Inc (NYSE:FLO) is actively innovating, with new products like small loaves and keto offerings showing promising growth. The company is experiencing substantial space gains in mass channels for its organic products, particularly Dave's Killer Bread, indicating strong market acceptance. Despite challenges, Flowers Foods Inc (NYSE:FLO) maintains a strong market share performance, particularly in premium and differentiated product segments. Negative Points The company is facing increased competitive pressure, particularly from new lower-priced bread products affecting traditional loaf sales. There is ongoing weakness in the away-from-home food service business, impacting overall performance. Flowers Foods Inc (NYSE:FLO) has reduced its EPS guidance, narrowing the gap between dividend commitments and current EPS run rate. The transition to align with shifting consumer trends is expected to take time, requiring patience from stakeholders. The company is experiencing negative fixed cost leverage due to lower volumes, impacting gross margins. Q & A Highlights Warning! GuruFocus has detected 6 Warning Sign with FLO. Q: Ryals, can you provide more details on the competitive environment and the impact of new lower-priced bread products? A: The promotional environment is elevated but stable. We've increased promotions, especially for differentiated products like Dave's Killer Bread (DKB), which performed well. Lower-priced entrants are affecting traditional loaf areas, but we're addressing this with our own small loaves. The market remains bifurcated, with good performance in premium and value segments, particularly in mass and club channels. We're also seeing continued weakness in the away-from-home food service business. Q: Steve, regarding the updated tariff outlook, have previous tariff costs been delayed or structurally updated? Also, how does the reduction in EPS guidance affect capital allocation, especially concerning dividends? A: The tariff update is structural, with expectations for tariffs to decrease based on current observations. Regarding capital allocation, we maintain a balanced approach, and the board evaluates performance, cash flow, and liquidity quarterly. We don't have a stated target payout ratio, but on a cash basis, it's different due to depreciation and amortization being above CapEx. Q: Are we returning to a highly competitive environment similar to years ago, with aggressive pricing strategies? A: The category is transitioning due to shifting consumer trends, such as health and wellness and ultra-processed food concerns. We're committed to innovation to navigate this transition. Traditional loaf products are most affected, but we're seeing success with differentiated products like DKB and Canyon Bakehouse. We have plans to address traditional loaf weaknesses, but I won't disclose details for competitive reasons. Q: Can you comment on the performance of Wonder and its impact on Tastykake? A: Wonder's launch has exceeded expectations without cannibalizing Tastykake, likely due to geographic strengths. Wonder is a national brand, while Tastykake is strong in the mid-Atlantic. We're pleased with Wonder's performance and have more innovation planned. Q: How long will the transition take, and are there near-term solutions to speed it up? A: The transition will take time, but I won't specify a duration. The category will stabilize eventually, driven by consumer behavior shifts and the pandemic's final effects. Our focus is on innovation to replace declines in traditional loaf sales. We have the number one brand and SKU, and we'll continue investing in brands like Nature Zone to mitigate losses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.